HomeTagsOLN324

Tag: OLN324

Johnson & Johnson to acquire...

Johnson & Johnson (J&J) has entered into...

Johnson & Johnson to acquire Ollin Biosciences for up to $3.3 billion

Johnson & Johnson (J&J) has entered into a definitive agreement to acquire Ollin Biosciences for $2.2 billion upfront, with additional regulatory and commercial milestone payments of up to approximately $1.125 billion. The transaction will add OLN324, an investigational bispecific antibody in Phase III development for retinal vascular diseases, to J&J’s pharmaceutical pipeline. Completion is expected before the end of 2026, subject to regulatory approvals and customary closing conditions. The proposed acquisition values Ollin at up to approximately $3.3 billion, including the potential milestone payments. It represents a strategic expansion of...

Johnson & Johnson...

Johnson & Johnson (J&J) has entered into a definitive agreement to acquire Ollin Biosciences for $2.2 billion upfront, with additional regulatory and commercial milestone...
spot_img

Create a website from scratch

With Newspaper Theme you can drag and drop elements onto a page and customize them to perfection. Try it out today and create the perfect site to express yourself!